This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
1. Review biomarkers of inflammation that have systemic affects on diverse body systems.
2. Review mediators of inflammation.3. Understand the mechanisms of action by which systemic
enzyme therapy with Wobenzym® decreases mediators of inflammation.
4. Understand clinical applications for systemic enzyme therapy with Wobenzym® as they relate to degenerative diseases and progression of senescence.
References: Each slide has its own numbered references in the Notes Page view of the presentation.
www.SystemicEnzymeSupport.org
Disclaimers: This presentation is for Educational Purposes Only. The entire contents of this presentation, are for informational purposes only. The contents are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this presentation. These statements made in this presentation have not been evaluated by the Food and Drug Administration and are not intended to be used to diagnose, treat, cure or prevent any diseases. The Content is the opinion of the author, and does not represent the opinion of any other party.
Copyright & Permissions: This entire presentation and all images herein are copyright of Joseph J Collins and SystemicEnzymeSupport.org. This presentation may be used for scientific, clinical and patient education in its entirety without editing or modification.
Systemic Enzyme Therapy (also called Systemic Enzyme Support) is a treatment modality that uses Wobenzym® formulations to increase serum levels of proteolytic enzymes, which in turn activate α-2-macroglobulin - a serum protein that facilitates the binding and removal of foreign peptides, excessive inflammatory mediators and auto-toxic endogenous proteins - and thereby support balanced humoral immune function and modulate systemic inflammation.
ESR:In RA patients free of overt arterial disease, there is a direct relationship between cumulative inflammatory burden (ESR area-under-the-curve-years) & arterial stiffness.[1]
Systemic Enzyme Therapy:Erythrocyte Sedimentation Rate (ESR) is lowered in RA patients treated with Wobenzym® N and Wobenzym® PS.[2,3,4]
Wobenzym® formulations lowered ESR levels in relapsing urinary tract infections, adnexitis , and acute trauma.[5,6,7]
Elevated Immunoglobulins occur in neuro-degenerative diseases such as Alzheimer’s (high Iga), as well as atopic dermatitis, recurrent infections, & rheumatoid arthritis.[1,2,3,4]
Systemic Enzyme Therapy:Wobenzym® PS therapy resulted in normalization of IgA in 60 %
of recurrent infection patients and reduction of primarily elevated IgE levels in 93 % of patients. [3]
Wobenzym® lowers autoimmune antibodies in autoimmune diseases such as rheumatoid arthritis and eczema. [2,4]
Elevated CIC are contributory to the progression of liver disease, atherosclerosis, complications for diabetes, myocardial re-infarction, atopic dermatitis, rheumatoid arthritis, Behcet's disease, and other immune complex diseases.[1,2,3,4,5,6,7,8,9]
Systemic Enzyme Therapy:Wobenzym® decreased CIC levels an additional 45% when
used as an adjuvant (with methotrexate) in rheumatoid arthritis.[8]
Wobenzym® lowered CIC levels in patients with liver disease, diabetes, myocardial infarction, atopic dermatitis & Behcet's disease.[1,2,3,4,5,6,7,9]
Imbalance of CytokinesIncreased pro-inflammatory cytokines (Th1) contribute to the
progression degenerative diseases such as rheumatoid arthritis, while excessive TGF-beta (a Th2 cytokine) is seen in many inflammatory disorders (pulmonary fibrosis, cataracts, & certain cancers).[1,2,3]
Increased fibrin activation and/or fibrosis is found in a number of acute & degenerative conditions including phlebitis, rheumatoid arthritis and some cancers.[1,2,3]
Systemic Enzyme Therapy:In postphlebitic syndrome, the effect of Wobenzym® PS therapy
was more pronounced (84% vs 73% for conventional therapy) due to increased blood fibrinolytic activity and inhibited platelet function.[1]
Both increased blood fibrinolytic activity and increased proteolysis of extravascularly deposited fibrin are observed in a number of clinical conditions treated with Wobenzym® .[1,2,3,4,5,6,7,8]
Increased Amyloid Production & DepositionAccumulation of beta-amyloid peptide in the brain plays a
central role in the development and progression of Alzheimer’s disease (AD).[1,2,3]
Systemic Enzyme Therapy:Wobenzym® activates alpha-2-macroglobulin and its receptor,
low density lipoprotein receptor-related protein (LRP), which function together to facilitate the cellular uptake and degradation of -amyloid peptide. [1,2,3]
Damaged Proteins and Cellular Debris The formation of toxic protein aggregates is a common denominator to many neurodegenerative diseases and aging. Accumulation of toxic, possibly infectious protein aggregates induces a cascade of events, such as excessive inflammation, the production of reactive oxygen species, apoptosis and neuronal loss.[1]
Systemic Enzyme Therapy:Wobenzym® activation of α2M modulates a potent chaperone-like action of α2M that has broad specificity for proteins partly unfolded as a result of heat or oxidative stress. α2M patrols extracellular spaces for unfolded/misfolded proteins and facilitate their disposal.[1,2]
Wobenzym® PS is delivered through tablets which have a special enteric coating that can withstand the acid environment in the stomach (very important since enzymes can be damaged by stomach acid). Once the tablet has passed a safe distance from the stomach acids, the tablet dissolves and the enzymes are efficiently absorbed by the mucosal membrane of the intestine. This process is most effective if the tablets are taken away from meals (45 minutes before meals or 1 ½ hour after meals).[1]
After being absorbed, the proteolytic enzymes tryspin and bromelain, from Wobenzym® PS, will preferentially complex to the bait region of alpha-2-macroglobulin (a2M)) to create α-2-macroglobulin-protease complexes.[1,2]
a2M, a high molecular weight plasma glycoprotein (8-10 % of total serum protein) that functions as a binding, carrier, and targeting protein. It binds host or foreign peptides and particles, thereby serving as humoral defense barriers against pathogens in both the plasma and the tissue.[3]
www.SystemicEnzymeSupport.org
Binding the Mediators of InflammationBinding the Mediators of Inflammation
This trapping of 2 protease molecules from Wobenzym® into the a2m changes the configuration of α-2-macroglobulin so that the newly activated α-2-macroglobulin-protease complex now has increased capacity for binding excessive interstitial and intravascular cytokines, immunoglobulins, fibrin, CRP, amyloid beta proteins, cell debris, and proteins damaged by oxidative stress and glycosylation.[1,2,3,4,5,6,7,8,9,10,11]
www.SystemicEnzymeSupport.org
Clearance of α-2M-Protease-MI Complexes Clearance of α-2M-Protease-MI Complexes
Wobenzym® PS increases alpha-2-macroglobulin-proteinase complexes, which are activated for receptor mediated endocytosis and are readily removed by hepatic α-2M-receptors (α-2M-R), as well as other cells expressing α-2M-R, such as macrophages. [1]
The alpha 2-macroglobulin-proteinase complexes promote macrophage locomotion and chemotaxis, such that the activated alpha 2-macroglobulin-proteinase complexes and the inflammatory mediators bound to the complex are cleared from the circulation very quickly by macrophages. [2,3]
www.SystemicEnzymeSupport.org
RESTORATION OF HEALTHY BIOMARKERSRESTORATION OF HEALTHY BIOMARKERS
Wobenzym® formulations are clinically effective in a broad range of degenerative conditions due to its immunomodulatory, anti-inflammatory, anti-edema, analgesic, fibrinolytic, thrombolysis, anti-tumor and antioxidant properties. Dozens of randomized, blinded and placebo studies have evidenced that the specific formulation can be used in various clinical specialties, including the following:
Immunology/Infectious DiseasesLymphologyNephrologyNeurologyOncologyOtolaryngologyPulmonologyTraumatology, SurgeryUrologyVascular Medicine
www.SystemicEnzymeSupport.org
Learn More About Wobenzym®Learn More About Wobenzym®
Professional Postersdigital copies of posters are on-line
www.SystemicEnzymeSupport.org• Tutorial on Systemic Enzyme Support• Conditions Treated with Systemic Enzymes• Clinical Research Summaries and Abstracts• Professional Articles (Technical)• Dosage Guidelines • Presentations• Contact Info
This presentation (references in note section) is available at: www.SystemicEnzymeSupport.org/presentations/